Staining by Brilliant Blue G in the intraocular surgery

Staining by Brilliant Blue G in the intraocular surgery - Staining by Brilliant Blue G in the intraocular surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011338

Enrollment

Registered

2013-08-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmic diseases targeted for intraocular surgery

Interventions

Use of Brilliant Blue G of the intraocular tissue staining during intraoperative surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) During intraocular surgery cases staining is necessary to anterior capsule of the lens and internal limiting membrane of the retina. 2) Patients were able gain agreement with from the person.

Exclusion criteria

Exclusion criteria: 1) Patients who may have been pregnant or pregnant women, patients who wish pregnancy and patient breastfeeding 2) External eye disease activity 3) Patients physician deems inappropriate

Design outcomes

Primary

Measure	Time frame
Evaluate the visual acuity, retinal thickness, field of view after surgery, evaluate the safety of the surgery method using this drug as compared to the conventional method.	—

Countries

Japan

Contacts

Public ContactMichiharu Shimizu

Kanazawa University Department of Ophthalmology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026